SynthesisFrontiers in pharmacology2024

Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis.

Yuting Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.